CORREVIO PHARMA CORP's ticker is CORV and the CUSIP is 22026V105. A total of 40 filers reported holding CORREVIO PHARMA CORP in Q1 2019. The put-call ratio across all filers is 2.68 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $41,000 | -98.5% | 101,100 | -92.8% | 0.00% | -100.0% |
| Q3 2019 | $2,827,000 | +108.5% | 1,413,475 | +125.1% | 0.03% | +116.7% |
| Q2 2019 | $1,356,000 | -11.1% | 628,000 | +30.2% | 0.01% | -7.7% |
| Q1 2019 | $1,525,000 | +27.0% | 482,500 | 0.0% | 0.01% | +18.2% |
| Q4 2018 | $1,201,000 | +17.2% | 482,500 | +89.3% | 0.01% | +57.1% |
| Q3 2018 | $1,025,000 | – | 254,900 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|